Literature DB >> 33362678

PET Imaging of Neutrophils Infiltration in Alzheimer's Disease Transgenic Mice.

Yanyan Kong1,2, Kawai Liu3, Tao Hua2, Chencheng Zhang1, Bomin Sun1, Yihui Guan2.   

Abstract

Neutrophils are important components in the innate immune system. Neutrophil hyperactivation is regarded as a characteristic of Alzheimer's disease (AD). But in vivo imaging tools observing neutrophil activity in AD dynamically is lacking. This study aimed to identify neutrophil infiltration in AD transgenic mice. We used the AD triple-mutant transgenic mouse model and identified the genotype with RT-PCR. Behavioral experiments including an open-field test, a Morris water maze, and a Y-maze test were performed to evaluate the status of this AD model. 18F-AV45, 18F-PM-PBB3, 68Ga-PEG-cFLFLFK, and 18F-DPA714 were synthesized according to previous reports. We employed microPET to detect tracer uptake in the AD model and the control mice at different stages. Western blotting was used to observe the expression of functional proteins. We proved the successful establishment of AD models by RT-PCR, behavioral tests, and 18F-AV45 and 18F-PM-PBB3 PET imaging. We found an increased neutrophil accumulation in the brains of the AD mice through 68Ga-PEG-cFLFLFK PET imaging and Western blot assay. Our studies also demonstrated an elevated level of CAP37, which is produced by neutrophils, in the AD brain, and treatment with CAP37 promoted the expression of Iba1, iNOS, and COX-2 in BV2 cultures. Furthermore, our 18F-DPA714 PET imaging studies verified the raised activation of microglia in the brain of transgenic AD mice. Collectively, our findings indicate the increased activity of neutrophils in the brain and heart of AD model mice, 68Ga-PEG-cFLFLFK PET imaging represents a sensitive method to observe the status of neutrophils in AD, and infiltrated neutrophils can induce the activation of microglia by releasing CAP37 and blocking the activity of neutrophils may be beneficial for the control of AD progression.
Copyright © 2020 Kong, Liu, Hua, Zhang, Sun and Guan.

Entities:  

Keywords:  Alzheimer's disease; Aβ; PET; neuroinflammation; neutrophils; tau

Year:  2020        PMID: 33362678      PMCID: PMC7758535          DOI: 10.3389/fneur.2020.523798

Source DB:  PubMed          Journal:  Front Neurol        ISSN: 1664-2295            Impact factor:   4.003


  40 in total

Review 1.  Immune attack: the role of inflammation in Alzheimer disease.

Authors:  Frank L Heppner; Richard M Ransohoff; Burkhard Becher
Journal:  Nat Rev Neurosci       Date:  2015-06       Impact factor: 34.870

Review 2.  Microglial phagocytosis in aging and Alzheimer's disease.

Authors:  Enrique Gabandé-Rodríguez; Lily Keane; Melania Capasso
Journal:  J Neurosci Res       Date:  2019-04-03       Impact factor: 4.164

Review 3.  SPECT and PET imaging in Alzheimer's disease.

Authors:  Varvara Valotassiou; Julia Malamitsi; John Papatriantafyllou; Efthimios Dardiotis; Ioannis Tsougos; Dimitrios Psimadas; Sotiria Alexiou; George Hadjigeorgiou; Panagiotis Georgoulias
Journal:  Ann Nucl Med       Date:  2018-08-20       Impact factor: 2.668

Review 4.  The Alzheimer's Disease Clinical Spectrum: Diagnosis and Management.

Authors:  Alireza Atri
Journal:  Med Clin North Am       Date:  2019-03       Impact factor: 5.456

5.  Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain.

Authors:  Seok Rye Choi; Geoff Golding; Zhiping Zhuang; Wei Zhang; Nathaniel Lim; Franz Hefti; Tyler E Benedum; Michael R Kilbourn; Daniel Skovronsky; Hank F Kung
Journal:  J Nucl Med       Date:  2009-10-16       Impact factor: 10.057

6.  Indium-111-labeled autologous leukocytes in man.

Authors:  M L Thakur; J P Lavender; R N Arnot; D J Silvester; A W Segal
Journal:  J Nucl Med       Date:  1977-10       Impact factor: 10.057

Review 7.  Tau PET imaging in neurodegenerative tauopathies-still a challenge.

Authors:  Antoine Leuzy; Konstantinos Chiotis; Laetitia Lemoine; Per-Göran Gillberg; Ove Almkvist; Elena Rodriguez-Vieitez; Agneta Nordberg
Journal:  Mol Psychiatry       Date:  2019-01-11       Impact factor: 15.992

8.  Brain network alterations in individuals with and without mild cognitive impairment: parallel independent component analysis of AV1451 and AV45 positron emission tomography.

Authors:  Yuan Li; Zhijun Yao; Yue Yu; Ying Zou; Yu Fu; Bin Hu
Journal:  BMC Psychiatry       Date:  2019-06-03       Impact factor: 3.630

9.  Impact of Chronic Risperidone Use on Behavior and Survival of 3xTg-AD Mice Model of Alzheimer's Disease and Mice With Normal Aging.

Authors:  Virginia Torres-Lista; Secundí López-Pousa; Lydia Giménez-Llort
Journal:  Front Pharmacol       Date:  2019-09-24       Impact factor: 5.810

10.  Microfluidic chemotaxis platform for differentiating the roles of soluble and bound amyloid-β on microglial accumulation.

Authors:  Hansang Cho; Tadafumi Hashimoto; Elisabeth Wong; Yukiko Hori; Levi B Wood; Lingzhi Zhao; Kevin M Haigis; Bradley T Hyman; Daniel Irimia
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

View more
  4 in total

Review 1.  Positron Emission Tomography in Animal Models of Tauopathies.

Authors:  Lei Cao; Yanyan Kong; Bin Ji; Yutong Ren; Yihui Guan; Ruiqing Ni
Journal:  Front Aging Neurosci       Date:  2022-01-10       Impact factor: 5.750

2.  Discerning the Role of Blood Brain Barrier Dysfunction in Alzheimer's Disease.

Authors:  Qing-Qing Tao; Rong-Rong Lin; Yi-He Chen; Zhi-Ying Wu
Journal:  Aging Dis       Date:  2022-10-01       Impact factor: 9.968

3.  Identification of genetic molecular markers and immune infiltration characteristics of Alzheimer's disease through weighted gene co-expression network analysis.

Authors:  KeFei Duan; Yuan Ma; Jin Tan; Yuyang Miao; Qiang Zhang
Journal:  Front Neurol       Date:  2022-08-22       Impact factor: 4.086

4.  Hub Genes, Diagnostic Model, and Predicted Drugs Related to Iron Metabolism in Alzheimer's Disease.

Authors:  Xuefeng Gu; Donglin Lai; Shuang Liu; Kaijie Chen; Peng Zhang; Bing Chen; Gang Huang; Xiaoqin Cheng; Changlian Lu
Journal:  Front Aging Neurosci       Date:  2022-07-07       Impact factor: 5.702

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.